<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In vivo magnetic resonance imaging was used to study the effect of ancrod (CAS 9046-56-4, Arwin), a plasma fibrinogen level lowering agent, on brain lesion in two rat models of <z:hpo ids='HP_0011009'>acute</z:hpo> focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Total lesion volume was determined by multislice T2-weighted magnetic resonance imaging 24 h after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Intravenous infusion of ancrod starting 30 min after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> at dosages of 10, 30, 50 or 70 IU/kg (n = 9/group) significantly diminished cerebral lesion volume by 20 to 33% as compared to vehicle-infused controls (n = 12) </plain></SENT>
<SENT sid="3" pm="."><plain>None of the ancrod-treated rats showed evidence of <z:mp ids='MP_0001916'>intracerebral bleeding</z:mp> on T2-weighted magnetic resonance images taken after 24 h </plain></SENT>
<SENT sid="4" pm="."><plain>In photochemically induced (<z:chebi fb="0" ids="52261">rose bengal</z:chebi>) unilateral thrombotic cortical infarction brain damage was displayed by multislice diffusion-weighted magnetic resonance imaging after 24 h </plain></SENT>
<SENT sid="5" pm="."><plain>Again, post treatment with ancrod reduced total volume of cerebral lesion dose-dependently from 142 +/- 28 mm3 in the controls (n = 10) to 121 +/- 28 mm3 (n = 10) and 111 +/- 20 mm3 (n = 11, p &lt; 0.05) in rats treated with 10 and 30 IU/kg ancrod, respectively (means +/- S.D.) </plain></SENT>
<SENT sid="6" pm="."><plain>These results suggest cerebroprotection in focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> by improvements in the cerebral microcirculation which may offer a potential and safe approach for therapy of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>